Breakthrough Pancreatic Cancer Treatment Phase III Trial Opens in Israel

Hope is that successful trials will allow Rafael Pharmaceuticals will receive expedited FDA approval by late 2020.

READ ARTICLE by Maayan Jaffe-Hoffman. Published by The Jerusalem Post, July 18, 2019.

Cancer cells [illustrative]. (photo credit: PIXABAY)